论文部分内容阅读
目的探讨自身免疫性肝硬化与乙型肝炎肝硬化合并食管胃静脉曲张内镜治疗后复发的临床特点。方法回顾性分析2006-2013年在解放军总医院消化内科行内镜下治疗的20例自身免疫性肝硬化合并食管胃静脉曲张患者治疗后复发的临床特点,并与同期住院的43例乙肝肝硬化合并食管胃静脉曲张患者的第1次内镜下治疗次数及治疗后复发时间进行对比。结果自身免疫性肝硬化和乙肝肝硬化患者第1次内镜治疗平均次数分别为2.10±1.25次和2.93±1.20次,两者差异有统计学意义(P<0.05),而且自身免疫性肝硬化复发时间较乙肝肝硬化提前(P<0.05),分别为0.70±0.44年和1.22±0.97年。结论内镜治疗后自身免疫性肝硬化较乙型肝炎肝硬化更早复发。
Objective To explore the clinical features of relapse after autoimmune cirrhosis and hepatitis B cirrhosis combined with esophagogastric varices endoscopy. Methods The clinical features of 20 patients with autoimmune cirrhosis complicated with esophagogastric varices after endoscopic treatment in Department of Gastroenterology, PLA General Hospital from 2006 to 2013 were analyzed retrospectively. The clinical characteristics of 43 patients with hepatitis B cirrhosis The first endoscopic treatment of patients with esophageal and gastric varices was compared with the recurrence time after treatment. Results The average number of first endoscopic treatment of patients with autoimmune cirrhosis and hepatitis B cirrhosis was 2.10 ± 1.25 times and 2.93 ± 1.20 times, respectively, with statistical significance (P <0.05), and autoimmune cirrhosis The recurrence time was earlier than that of hepatitis B cirrhosis (P <0.05), which was 0.70 ± 0.44 years and 1.22 ± 0.97 years, respectively. Conclusion Endoscopic treatment of autoimmune cirrhosis than hepatitis B cirrhosis recurrence.